Suppr超能文献

肝素诱导抗体的时效性:一项针对接受普通肝素血液透析门诊患者的回顾性研究。

Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin.

作者信息

Maharaj Satish, Chang Simone, Seegobin Karan, Morales James, Aysola Agnes, Rana Fauzia, Shaikh Marwan

机构信息

1Division of Hematology and Medical Oncology, Department of Internal Medicine, University of Florida College of Medicine-Jacksonville, UF Health Jacksonville, 653 W 8th St, Jacksonville, FL 32209 USA.

2University of Miami Health System, Miami, FL USA.

出版信息

Exp Hematol Oncol. 2018 Sep 14;7:23. doi: 10.1186/s40164-018-0115-8. eCollection 2018.

Abstract

BACKGROUND

Heparin-induced antibodies (HIA) are responsible for causing heparin-induced thrombocytopenia and thrombosis. Research has shown that the temporality of heparin-induced antibodies does not follow the classic immunologic response. The immunobiology of HIA generation remains unclear with varying in vitro and in vivo data. Outpatients undergoing hemodialysis (HD) are exposed to heparin chronically. The HIA immune response can therefore be investigated in vivo in this population.

METHODS

We examined the time between the start of HD using unfractionated heparin and HIA levels in 212 outpatients during a 6-year period. Antibodies were detected on enzyme-linked immunosorbent assay. HIA levels were analyzed to determine significance of the trend over time. HIA subgroups were also analyzed for correlation with subsequent thrombotic events and platelet count during follow up.

RESULTS

Overall, the HIA response in HD was found to peak early with waning antibody response despite continued exposure to heparin. The peak prevalence of a strong immune response (optical density > 1.000) was early and short lived, while weaker immune response (optical density 0.400-1.000) persisted for the first 6 months then declined. The mean follow-up time per patient was 2.3 ± 1.4 years. Despite circulating HIA, including high titers, no patients developed HIT in this sample. There was no association between HIA and thrombocytopenia. There was increased incidence of thrombosis in patients with strong HIA compared to other groups, but this did not achieve statistical significance.

CONCLUSIONS

The data suggest a significant temporal pattern of HIA in outpatients undergoing HD using unfractionated heparin. Positive HIA was not found to be significantly associated with thrombocytopenia or thrombosis risk in these patients. However, while not achieving statistical significance, subsequent thrombotic events occurred most frequently in the strong positive HIA group (optical density > 1.000). Further research into HIA and risk of thrombosis in this population is needed.

摘要

背景

肝素诱导的抗体(HIA)可导致肝素诱导的血小板减少症和血栓形成。研究表明,肝素诱导抗体的时效性并不遵循经典的免疫反应。HIA产生的免疫生物学机制仍不清楚,体外和体内数据存在差异。接受血液透析(HD)的门诊患者长期接触肝素。因此,可以在该人群中对HIA免疫反应进行体内研究。

方法

我们在6年期间检查了212例门诊患者使用普通肝素开始血液透析与HIA水平之间的时间关系。通过酶联免疫吸附测定法检测抗体。分析HIA水平以确定随时间变化趋势的显著性。还分析了HIA亚组与随访期间随后发生的血栓事件和血小板计数的相关性。

结果

总体而言,发现HD患者中的HIA反应早期达到峰值,尽管持续接触肝素,但抗体反应逐渐减弱。强烈免疫反应(光密度>1.000)的峰值患病率出现较早且持续时间短,而较弱免疫反应(光密度0.400 - 1.000)在最初6个月持续存在,然后下降。每位患者的平均随访时间为2.3±1.4年。尽管存在循环HIA,包括高滴度,但该样本中没有患者发生肝素诱导的血小板减少症(HIT)。HIA与血小板减少症之间没有关联。与其他组相比,HIA强阳性患者的血栓形成发生率增加,但未达到统计学显著性。

结论

数据表明,在使用普通肝素进行血液透析的门诊患者中,HIA存在显著的时间模式。在这些患者中,未发现阳性HIA与血小板减少症或血栓形成风险有显著关联。然而,虽然未达到统计学显著性,但随后的血栓事件最常发生在HIA强阳性组(光密度>1.000)。需要对该人群中HIA与血栓形成风险进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5712/6137914/92de5f51f76f/40164_2018_115_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验